GSK 2830371
-
GSK 2830371
structure -
-
CAS No:
1404456-53-6
-
Formula:
C23H29ClN4O2S
-
Chemical Name:
GSK 2830371
-
Synonyms:
GSK 2830371;5-[[(5-Chloro-2-methyl-3-pyridinyl)amino]methyl]-N-[(1S)-1-(cyclopentylmethyl)-2-(cyclopropylamino)-2-oxoethyl]-2-thiophenecarboxamide;(S)-5-((5-chloro-2-methylpyridin-3-ylamino)methyl)-N-(3-cyclopentyl-1-(cyclopropylamino)-1-oxopropan-2-yl)thiophene-2-carboxamide
- Categories:
-
CAS No:
Characteristics
111
5.2
white to beige
1.30±0.1 g/cm3(Predicted)
704.1±60.0 °C(Predicted)
DMSO: soluble20mg/mL, clear
2-8°C
Computed Properties
Molecular Weight:461.0
XLogP3:5.2
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:9
Exact Mass:460.1699750
Monoisotopic Mass:460.1699750
Topological Polar Surface Area:111
Heavy Atom Count:31
Complexity:629
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Latest News on GSK 2830371
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
GSK 2334470
1227911-45-6
-
GSK 690693
937174-76-0
-
GSK 343
1346704-33-3
-
GSK 3 inhibitor XVI Formula
252917-06-9
-
GSK 625433 Formula
885264-71-1
-
GSK J4 HCl Formula
1373423-53-0
-
Dabrafenib Structure
1195765-45-7
-
BOC-VAL-VAL-OH Structure
69209-73-0
-
What is BMS 303141
943962-47-8
-
What is (2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide
60117-17-1